Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years

Quan Liao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1324-6213; OpenAlex author ID A5071746289. Sources: OpenAlex.

Their work

Papers
15 (first author 2, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
39
Papers, trials and grants by year

2012: 1 paper · 2013: 2 papers · 2014: 1 paper · 2015: none · 2016: 2 papers · 2017: none · 2018: none · 2019: 1 paper · 2020: 2 papers · 2021: 4 papers · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 15

  1. Comparative spatial transcriptomics of pancreatic cancer with ductal and acinar origins in mouse models. Co-author DOI 10.1002/ctm2.70416↗
  2. Pancreatic cancer cell-derived migrasomes promote cancer progression by fostering an immunosuppressive tumor microenvironment. Co-author DOI 10.1016/j.canlet.2024.217289↗
  3. Radical antegrade modular pancreatosplenectomy (RAMPS) versus conventional distal pancreatosplenectomy (CDPS) for left-sided pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00595-020-02203-3↗
  4. Immune subtyping for pancreatic cancer with implication in clinical outcomes and improving immunotherapy. Last author DOI 10.1186/s12935-021-01824-z↗
  5. Upregulated CD58 is associated with clinicopathological characteristics and poor prognosis of patients with pancreatic ductal adenocarcinoma. Last author DOI 10.1186/s12935-021-02037-0↗
  6. [Expression and Prognostic Value of Cripto-1 in Pancreatic Cancer]. Last author DOI 10.3881/j.issn.1000-503x.12734↗
  7. Identification of prognosis-related genes and construction of multi-regulatory networks in pancreatic cancer microenvironment by bioinformatics analysis. Co-author DOI 10.1186/s12935-020-01426-1↗
  8. High Expression of Cancer-Derived Glycosylated Immunoglobulin G Predicts Poor Prognosis in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.7150/jca.39800↗
  9. Fibroblast activation protein α-positive pancreatic stellate cells promote the migration and invasion of pancreatic cancer by CXCL1-mediated Akt phosphorylatio… Last author DOI 10.21037/atm.2019.09.164↗
  10. Prognostic Impact of Cell Division Cycle Associated 2 Expression on Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1016/s1001-9294(16)30043-8↗
  11. A Single Talent Immunogenic Membrane Antigen and Novel Prognostic Predictor: voltage-dependent anion channel 1 (VDAC1) in Pancreatic Cancer. Co-author DOI 10.1038/srep33648↗
  12. High expression of interleukin-22 and its receptor predicts poor prognosis in pancreatic ductal adenocarcinoma. First author DOI 10.1245/s10434-013-3322-x↗
  13. A spheroid-based 3-D culture model for pancreatic cancer drug testing, using the acid phosphatase assay. First author DOI 10.1590/1414-431x20132647↗
  14. [The role of perioperative enteral and parenteral nutrition treatment in pancreatic cancer: a multicenter, prospective randomized controlled trial]. Co-author PMID 24444682↗
  15. [Validation of candidate immunogenic membrane antigens of human pancreatic cancer screened by proteomics]. Co-author PMID 22800753↗

Closest collaborators

The 25 strongest of 39 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Qiaofei Liu · 7 shared papers, 2019–2024 · strength 0.98
  2. Ming Cui · 4 shared papers, 2020–2025 · strength 0.66
  3. Yupei Zhao · 5 shared papers, 2014–2025 · strength 0.58
  4. Yalu Zhang · 3 shared papers, 2021–2024 · strength 0.52
  5. Tong Li · 3 shared papers, 2020–2024 · strength 0.47
  6. Sen Yang · 2 shared papers, 2024–2025 · strength 0.41
  7. Lei You · 3 shared papers, 2014–2025 · strength 0.38
  8. Jingkai Liu · 2 shared papers, 2021 · strength 0.34
  9. Ronghua Zhang · 2 shared papers, 2020–2024 · strength 0.32
  10. Boju Pan · 2 shared papers, 2020–2021 · strength 0.27
  11. Taiping Zhang · 4 shared papers, 2012–2021 · strength 0.26
  12. Yu-Pei Zhao · 4 shared papers, 2012–2020 · strength 0.26
  13. Jin Peng He · 1 shared paper, 2025 · strength 0.23
  14. Kevin C. Soares · 1 shared paper, 2025 · strength 0.23
  15. Junyi Gao · 1 shared paper, 2024 · strength 0.18
  16. Junya Peng · 1 shared paper, 2024 · strength 0.18
  17. Jorg H. Kleeff · 1 shared paper, 2024 · strength 0.18
  18. Menghua Dai · 2 shared papers, 2013–2021 · strength 0.16
  19. Junchao Guo · 2 shared papers, 2013–2021 · strength 0.16
  20. Xiang Gao · 1 shared paper, 2021 · strength 0.16
  21. Qiang Xu · 1 shared paper, 2021 · strength 0.16
  22. Xiang Zhang · 1 shared paper, 2021 · strength 0.15
  23. Cheng Ding · 1 shared paper, 2021 · strength 0.12
  24. Qiang Xu · 1 shared paper, 2021 · strength 0.12
  25. Xianlin Han · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.